LOAd713 treatment decreased multiple profibrotic factors including LAP-TGF-β1, type I collagen, FGF5, HGF, and TWEAK. LOAd713 increased immune cell infiltration, inhibited tumor growth, and prolonged survival in syngeneic mouse models of melanoma. The gene discussed is TGFB1; the disease is neoplasm.